Form 4 for TXG 10x Genomics, Inc.
Accepted 2022-02-10 00:00:00 ET · period of report 2022-02-08 · accession 0001567619-22-003272 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-10 | 2022-02-08 | TXG | Saxonov Serge | CEO, Dir | S - Sale+OE | $89.90 | -12.0K | 924.4K | -1% | -$1.08M |
| D | 2022-02-10 | 2022-02-08 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $11.48 | +3,038 | 925.3K | +0.3% | +$34.9K |
| D | 2022-02-10 | 2022-02-08 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $0.00 | -3,038 | 42.5K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-08 | S | D | 2,397 | $91.04 | 913,293 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $90.765 to $91.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2022-02-08 | S | D | 4,200 | $89.19 | 920,193 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $88.66 to $89.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2022-02-08 | S | D | 4,503 | $90.30 | 915,690 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $89.76 to $90.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2022-02-08 | M | A | 3,038 | $11.48 | 925,293 | D | — | — | |
| 5 | Common | Class A Common Stock | 2022-02-08 | S | D | 900 | $88.17 | 924,393 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $87.64 to $88.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Derivative | Stock Option (right to buy) | 2022-02-08 | M | D | 3,038 | $0.00 | 42,521 | D | $11.48 · — to 2029-05-10 | 3,038 Class A Common Stock | (F8) This option, originally for 145,786 shares, of which 103,265 have been exercised, vested as to 1/48th of the shares on May 1, 2019, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |